Ernst & Young CEO Expects $10B From Tech Giant Contracts After Historical Business Split: Report
Ernst & Young’s global CEO said that the business split would win its consulting division as much as $10 billion…
EXCLUSIVE: Adial Pharma’s AD04 Effective In Heavy Drinker Alcohol Use Disorder Patients
Adial Pharmaceuticals Inc's (NASDAQ: ADIL) ONWARD Phase 3 study of AD04 for Alcohol Use Disorder (AUD) achieved a statistically significant mean reduction in heavy drinking days compared to placebo.
Novavax’s COVID-19 Vaccine For Adults Gets CDC Advisory Committee Recommendation
The U.S. Centers for Disease Control and Prevention’s (CDC) advisory committee recommended using Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine as a two-dose…
RBC Capital Lowers Inovio Price Target As It Awaits This
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ:INO) to $4 from $5 with a Sector Perform rating.…
JMP Is Bullish On This Cancer Stock “Sees New Way to Treat Cancer”
JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ:AURA) with a Market Outperform rating and a $26 risk-adjusted price target. Aura…
Ultragenyx Shares Tumble On Initial Efficacy Missing Expectations, This Analyst Sees ‘Viable Path Forward”
Earlier today, Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) released updated interim GTX-102 data, including Day 128 assessments from 9 patients. The Overall CGI-C-AS…
HC Wainwright Initiates Coverage On Upcoming Complement Franchise Company Apellis Pharmaceuticals
HC Wainwright has initiated coverage on Apellis Pharmaceuticals Inc (NASDAQ:APLS) with a Buy rating and a $75 price target. The analyst expects Apellis’s…
European Commission Signs COVID-19 Drug Procurement Deal With Gilead
Gilead Sciences Inc (NASDAQ:GILD) and the European Commission signed a joint procurement agreement for rapid and equitable access to the COVID-19…
Scynexis Touts Postive Data For Ibrexafungerp For Vaginal Infections
Scynexis Inc (NASDAQ:SCYX) announced the presentation of positive outcomes from the CANDLE 304s nested sub-study of ibrexafungerp in recurrent vulvovaginal candidiasis…
Inovio Lays Out Corporate Reorganization To Extend Cash Runway Into 2024
Inovio Pharmaceuticals Inc (NASDAQ:INO) has implemented a corporate reorganization designed to extend its cash runway and focus on key clinical programs.…